公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2010 | Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma | Chiang C.-T.; Yeh P.-Y.; Gao M.; Chen C.-W.; Yeh L.-C.; Feng W.-C.; SUNG-HSIN KUO ; CHIH-HUNG HSU ; YEN-SHEN LU ; ANN-LII CHENG | Cancer Letters | 19 | 19 | |
2012 | Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma | Yen T.-J.; Chung C.-S.; YEN-WEN WU ; RUOH-FANG YEN ; MEI-FANG CHENG ; JANG-MING LEE ; CHIH-HUNG HSU ; YIH-LEONG CHANG ; HSIU-PO WANG | Diseases of the Esophagus | 33 | 30 | |
2007 | Comparison of the phosphorylation of 4′-ethynyl 2′,3′- dihydro3′-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs | CHIH-HUNG HSU ; Hu R.; Dutschman G.E.; Yang G.; Krishnan P.; Tanaka H.; Baba M.; Cheng Y.-C. | Antimicrobial Agents and Chemotherapy | 14 | 13 | |
2006 | Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: A two-case study | CHIA-CHI LIN ; CHIH-HUNG HSU ; YEONG-SHIAU PU | Anticancer Research | 0 | 0 | |
1999 | Concurrent chemoradiotherapy for locally advanced esophageal cancer - A pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil | CHIH-HUNG HSU ; KUN-HUEI YEH ; Lui L.T.; Lee Y.-C.; Bu C.-F.; HSIU-PO WANG ; Lin J.-T.; ANN-LII CHENG | Anticancer Research | 29 | 26 | |
2007 | Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer | CHIA-CHI LIN ; CHIH-HUNG HSU ; CHIA-HSIEN CHENG ; HSIU-PO WANG ; JANG-MING LEE ; KUN-HUEI YEH ; CHIH-HSIN YANG ; Lin J.-T.; ANN-LII CHENG ; Lee Y.-C. | Annals of Oncology | 39 | 36 | |
2019 | Considerations of heterogeneity in clinical trials for hepatocellular carcinoma | TSUNG-HAO LIU ; YU-YUN SHAO ; LI-CHUN LU ; Ying-Chun Shen ; CHIUN HSU ; ZHONG-ZHE LIN ; CHIH-HUNG HSU ; ANN-LII CHENG | Expert Review of Gastroenterology and Hepatology | 5 | 7 | |
2000 | Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis | Chuang S.E.; Kuo M.L.; CHIH-HUNG HSU ; Chen C.R.; Lin J.K.; Lai G.M.; CHANG-YAO HSIEH ; ANN-LII CHENG | Carcinogenesis | 240 | 210 | |
2022 | Cyclin-Dependent Kinase 9 Inhibition as a Potential Treatment for Hepatocellular Carcinoma | YU-YUN SHAO ; Hsu, Hung-Wei; Wo, Rita Robin; Wang, Han-Yu; ANN-LII CHENG ; CHIH-HUNG HSU | Oncology | 3 | 3 | |
2023 | Defining conversion therapy for esophageal squamous cell carcinoma | Matsuda, Satoru; Tsushima, Takahiro; Kato, Ken; CHIH-HUNG HSU ; JANG-MING LEE ; Wong, Ian Yu Hong; Wang, Hu Lin Christina; Kang, Chang Hyun; Guo, Xufeng; Yamamoto, Shun; Tsuji, Takayuki; Kawakubo, Hirofumi; Takeuchi, Hiroya; Law, Simon; Kitagawa, Yuko | Annals of Gastroenterological Surgery | 0 | 1 | |
2022 | Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinoma | JHE-CYUAN GUO ; CHIA-CHI LIN ; Hsu, Chia-Lang; TA-CHEN HUANG ; HUNG-YANG KUO ; Lin, Chen-Yuan; Lien, Ming-Yu; ANN-LII CHENG ; CHIH-HUNG HSU | Esophagus : official journal of the Japan Esophageal Society | 0 | 0 | |
2012 | Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma | Shau W.-Y.; YU-YUN SHAO ; Yeh Y.-C.; ZHONG-ZHE LIN ; Kuo R.; CHIH-HUNG HSU ; CHIUN HSU ; ANN-LII CHENG ; Lai M.-S. | Oncologist | 32 | 32 | |
2023 | Different immune contextures underlie tumor site-specific responses to immune checkpoint blockade in esophageal cancer | JHE-CYUAN GUO ; Hsu, Chia-Lang; MIN-SHU HSIEH ; CHIA-CHI LIN ; TA-CHEN HUANG ; HUNG-YANG KUO ; YU-YUN SHAO ; CHIH-HUNG HSU | Thoracic cancer | 0 | 0 | |
2019 | Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma | LI-CHUN LU ; CHIUN HSU ; YU-YUN SHAO ; Chao Y.; Yen C.-J.; I-LUN SHIH ; Hung Y.-P.; Chang C.-J.; Ying-Chun Shen ; JHE-CYUAN GUO ; TSUNG-HAO LIU ; CHIH-HUNG HSU ; ANN-LII CHENG | Liver Cancer | 46 | 44 | |
2008 | Disseminated peritoneal leiomyomatosis responds to systemic chemotherapy | Lin Y.-C.; LING-HUNG WEI ; CHIA-TUNG SHUN ; ANN-LII CHENG ; CHIH-HUNG HSU | Oncology | 28 | 20 | |
2012 | Dissimilar immunohistochemical expression of ERK and AKT between paired biopsy and hepatectomy tissues of hepatocellular carcinoma | YU-YUN SHAO ; Chen C.-L.; MING-CHIH HO ; Huang C.-C.; Tu H.-C.; CHIH-HUNG HSU ; ANN-LII CHENG | Anticancer Research | 9 | 10 | |
2004 | Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy | CHIH-HUNG HSU ; Hsu H.-C.; Chen H.-L.; Gao M.; Yeh P.-Y.; PEI-JER CHEN ; ANN-LII CHENG | Anticancer Research | 47 | 41 | |
2021 | Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma | BANG-BIN CHEN ; YU-YUN SHAO ; ZHONG-ZHE LIN ; CHIH-HUNG HSU ; ANN-LII CHENG ; CHIUN HSU ; PO-CHIN LIANG ; TIFFANY TING-FANG SHIH | Diagnostics (Basel, Switzerland) | 7 | 7 | |
2011 | Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil | CHAO-YU HSU ; Ying-Chun Shen ; CHIH-WEI YU ; CHIUN HSU ; Hu F.-C.; CHIH-HUNG HSU ; BANG-BIN CHEN ; Wei S.-Y.; ANN-LII CHENG ; TIFFANY TING-FANG SHIH | Journal of Hepatology | 106 | 100 | |
2016 | Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy | BANG-BIN CHEN ; CHAO-YU HSU ; CHIH-WEI YU ; PO-CHIN LIANG ; CHIUN HSU ; CHIH-HUNG HSU ; ANN-LII CHENG ; TIFFANY TING-FANG SHIH | Radiology | 27 | 25 | |